SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-18-026874
Filing Date
2018-04-26
Accepted
2018-04-26 07:04:46
Documents
5
Effectiveness Date
2018-04-26

Document Format Files

Seq Description Document Type Size
1 DEFA14A a18-9208_3defa14a.htm DEFA14A 33537
2 GRAPHIC g92083bgi001.gif GRAPHIC 94875
3 GRAPHIC g92083bgi002.gif GRAPHIC 88311
4 GRAPHIC g92083bgi003.gif GRAPHIC 54013
5 GRAPHIC g92083bgi004.gif GRAPHIC 66507
  Complete submission text file 0001104659-18-026874.txt   453354
Mailing Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37813 | Film No.: 18776101
SIC: 2834 Pharmaceutical Preparations